• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Insulet launches National Diabetes Month initiatives

November 1, 2023 By Sean Whooley

Insulet Nasdaq
This marks the ninth straight year the company appears at the Nasdaq Stock Market. [Image from Insulet on LinkedIn in 2021]
Insulet (Nasdaq:PODD) today announced a series of initiatives to recognize National Diabetes Awareness Month and World Diabetes Day.

The U.S. recognizes the month of November as National Diabetes Awareness Month, while World Diabetes Day falls on Nov. 14.

To recognize World Diabetes Day, Insulet’s team will appear at the Nasdaq Stock Market for the ninth consecutive year. Hollingshead and a group of global Insulet employees and customers will mark the day by ringing the Nasdaq’s closing bell. They also intend to speak about the importance of raising diabetes awareness, plus Insulet’s mission.

Earlier that day, Insulet plans for its employees to join the American Association of Nurse Practitioners (AANP) at NBC’s TODAY Show. This intends to recognize Nurse Practitioner Week and the role nurse practitioners play in diabetes management.

“Our commitment to people with diabetes extends beyond our innovative insulin delivery technology,” said Jim Hollingshead, Insulet president and CEO. “World Diabetes Day may be just one day on the calendar, but for those living with diabetes, every day requires resilience and strength. By raising awareness today, we pave the way for a world where care, support, and understanding are accessible to all who need it.”

See examples of initiatives set out by a range of diabetes tech companies in November 2022.

Other Insulet initiatives in November

Throughout the month, Insulet plans for a series of campaigns and events to raise awareness for diabetes.

The company endorsed an international campaign to eliminate diabetes stigma and discrimination. With the diaTribe Foundation and the Australian Centre for Behavioural Research in Diabetes, the global diabetes company intends to endorse the “Pledge to End Diabetes Stigma.” They plan to encourage non-profits, industry partners, healthcare professionals, people with diabetes, allies and the general public to join.

Additionally, Insulet invited members of the Association of Diabetes Care and Education Specialists (ADCES) in New England to its headquarters. The event, in Acton, Massachusetts, aims to empower and support clinicians in their care of people with diabetes.

Insulet also began a social media movement called the “#JustMyType” campaign. It intends to feature content on its social media channels and encourage others to participate on their own channels. #JustMyType creates awareness and increases the representation of people with diabetes online.

Finally, the company plans to co-host a special event for Omnipod users on Nov. 11. With Dexcom CGM users from Germany and the UK, they hope to educate the public, broaden awareness and inspire people with diabetes.

Orli Adamski, a 16-year-old New York-based advocate for people with diabetes, will join Insulet at the Nasdaq ceremony.

“There are no breaks with type 1 diabetes,” said Adamski. “It impacts every single moment of my life, and so many other lives. It’s important to create awareness of the challenges that people with diabetes face, including gaining access to technology like Omnipod 5.”

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Technology Tagged With: Insulet

IN CASE YOU MISSED IT

  • What the launch of Mobi for Android means for Tandem, people with diabetes
  • Go-Pen wins CE mark for user-fillable insulin pen
  • Tandem wins FDA nod to pair Mobi pump with Android smartphones
  • The top CGM stories of 2025
  • Billie Jean King supports Medtronic Diabetes awareness initiative

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS